Theseus Pharmaceuticals Ratios and Metrics

Market cap in millions CAD. Fiscal year is August - July.

Millions CAD. Fiscal year is Aug - Jul.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2016 - 2020
Period Ending	Aug '25 Aug 1, 2025	Jul '24 Jul 31, 2024	Jul '23 Jul 31, 2023	Jul '22 Jul 31, 2022	Jul '21 Jul 31, 2021	Jul '20 Jul 31, 2020	2016 - 2020
Market Capitalization	14	11	10	8	3	3	Upgrade
Market Cap Growth	151.13%	15.55%	23.93%	210.52%	-3.91%	15.63%	Upgrade
Enterprise Value	14	12	9	7	3	3	Upgrade
Last Close Price	0.12	0.13	0.12	0.12	0.08	0.10	Upgrade
PB Ratio	571.19	-8.39	8.54	7.53	-5.10	-8.80	Upgrade
P/TBV Ratio	349.55	-	8.39	7.53	-	-	Upgrade
Debt / Equity Ratio	28.93	-0.65	0.16	0.18	-0.37	-0.70	Upgrade
Quick Ratio	0.46	0.02	0.58	2.61	0.03	0.22	Upgrade
Current Ratio	0.46	0.06	1.58	2.82	0.03	0.26	Upgrade
Return on Equity (ROE)	-	-	-178.14%	-687.67%	-	-	Upgrade
Return on Assets (ROA)	-62.37%	-98.72%	-59.49%	-89.11%	-86.17%	-141.57%	Upgrade
Return on Capital (ROIC)	-204.65%	-308.01%	-72.79%	-160.59%	-	-	Upgrade
Earnings Yield	-12.67%	-19.95%	-19.78%	-23.94%	-18.71%	-32.11%	Upgrade
FCF Yield	-11.53%	-9.61%	-23.68%	-28.44%	-9.08%	-10.76%	Upgrade
Buyback Yield / Dilution	19.99%	-4.58%	-66.80%	-54.43%	-47.37%	-31.82%	Upgrade

Updated Dec 31, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.